Kham M Trinh

Title: Kham M Trinh: Innovator in Cancer Therapy

Introduction

Kham M Trinh is a notable inventor based in Alhambra, CA (US), recognized for his contributions to cancer treatment through innovative therapies. He holds a total of 5 patents that focus on enhancing the efficacy of adoptive T cell therapies.

Latest Patents

One of his latest patents involves the development of antibody-interferon fusion proteins aimed at boosting the cancer-fighting capacity of adoptive T cell therapies. This method utilizes antibody-interferon (Ab-IFN) fusion proteins to enhance the ability of T cells, which are manipulated and grown outside the body, to target and destroy tumors effectively. Another significant patent focuses on anti-CSPG4 fusions with interferon for treating malignancies. This invention includes chimeric constructs that demonstrate substantial efficacy against various cancers by combining a targeting moiety that binds specifically to CSPG4 with different forms of interferon.

Career Highlights

Kham M Trinh has worked with prestigious organizations such as the University of California and Origen Therapeutics, Inc. His work has significantly impacted the field of cancer immunotherapy, showcasing his commitment to advancing medical science.

Collaborations

Throughout his career, Kham has collaborated with esteemed colleagues, including Sherie L Morrison and John M Timmerman, contributing to the development of innovative cancer therapies.

Conclusion

Kham M Trinh's work in the field of cancer treatment through innovative therapies highlights his dedication to improving patient outcomes. His patents and collaborations reflect a significant contribution to medical science, particularly in the realm of adoptive T cell therapies.